Process development

Process development

featured image of Revolutionary iPSCs: The Future of Advanced Therapies

Revolutionary iPSCs: The Future of Advanced Therapies

BIOT

📰 iPSCs: The Holy Grail of Advanced Therapies! 🧬 Scalability, cost-effectiveness, and super-donors are the keys to success. 💰 CCRM leads the way!

featured image of Revolutionizing Bioprocessing: Virtual Bioreactors & AI

Revolutionizing Bioprocessing: Virtual Bioreactors & AI

BIOT

📌 Discover how upstream bioprocessing is revolutionizing biotherapeutics with nondestructive monitoring, in silico modeling, and improved fluid dynamics! 🧪🔬🚀

featured image of Revolutionizing Bioprocessing: Boost Production and Achieve Scalability

Revolutionizing Bioprocessing: Boost Production and Achieve Scalability

BIOT

🔍 Upstream bioprocessing can be more intense and stable with holistic monitoring and control technologies. 🔬 Experts discuss platforms for industrializing cell therapy, machine-learning-assisted clone selection, microbioreactors for modeling large-scale processes, and streamlined process analytical technology. 📊 These options can boost production and achieve a state of readiness in biomanufacturing. 🚀 The goal is to have a reliable and scalable platform from the start. 🧪 Artificial intelligence can help predict clone performance in intensified processes. 🌱 Clones optimized for fed-batch processes may not be ideal for perfusion processes. ⚙️ True perfusion processes should start with clones optimized for perfusion conditions.

featured image of Revolutionary AI Tool for Accurate Metabolomics Analysis

Revolutionary AI Tool for Accurate Metabolomics Analysis

BIOT

📰 Simple, Scalable Absolute Concentrations in Untargeted Metabolomics explores the power of Pyxis, an AI-enabled technology 🧪💻 that revolutionizes analysis and provides precise absolute analyte concentrations. Discover the benefits of absolute quantitation!

featured image of Revolutionary IRO Platform Accelerates Cell and Gene Therapy Manufacturing

Revolutionary IRO Platform Accelerates Cell and Gene Therapy Manufacturing

BIOT

🌟 Ori Biotech launches IRO platform to tackle cell and gene therapy manufacturing challenges. 🧬 Flexibility, scalability, and faster development timelines. 💪🚀 Increasing patient access to life-saving therapies. 💉🧬

featured image of Regulators Threaten Biosimilars Boost for LMICs

Regulators Threaten Biosimilars Boost for LMICs

BIOT

📰 Western regulators threaten the future of biosimilars, pushing innovation and cost reduction to low and medium-income countries. 😱🌍

featured image of Unlocking Vibrio's Potential: The Future of Bioprocessing

Unlocking Vibrio’s Potential: The Future of Bioprocessing

BIOT

Converging Roads in Bioprocessing explores the potential of using Vibrio in synthetic biology and bioprocessing. 🦠🧪🔬

featured image of Unlock Success: Partner with CDMOs for Cell Therapy Manufacturing

Unlock Success: Partner with CDMOs for Cell Therapy Manufacturing

BIOT

📅 May 29, 2024: 🧪 Small biotech companies should engage a CDMO early for cell therapy GMP manufacturing. 📝 Documentation, quality control, and trust are key.

featured image of Revolutionary Tech: Solving Healthcare Costs with QTL

Revolutionary Tech: Solving Healthcare Costs with QTL

BIOT

🔍✨ Can new technologies tackle the escalating cost of healthcare? 📚🧬🔄 Discover how QTL technology and lifestyle interventions can make a difference.

featured image of Revolutionary Tech: Solving Healthcare Costs with QTL

Revolutionary Tech: Solving Healthcare Costs with QTL

BIOT

📅 May 20, 2024: Escalating healthcare costs due to diseases 📈, but 💡new technologies like QTL can help! 🔬🔬 Understanding complex systems is key. ♻️